BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Clinical - Drug Product News (World)
CorMedix (CRMD) Release: Neutrolin Label Expansion Approved For The European Union 9/22/2014
Janssen Pharmaceutical Inc. Release: Prezcobix™ Now Available For Canadians Living With HIV 9/17/2014
Novartis AG (NVS), Roche (RHHBY) Cry Foul On New Swiss Pricing System 9/16/2014
Roche (RHHBY) Battles Counterfeit Rituxin Vials In Germany 9/15/2014
EMD Serono Canada Inc. Announces Launch Of The Eeva® Test In Canada 9/11/2014
Endo International plc (ENDP) Announces Launch Of Authorized Generic Of FORTESTA® Gel 9/8/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of Generic Baraclude® Tablets, 0.5mg And 1mg, In The United States 9/4/2014
Cipla Ltd. Takes A Bite Out Of GlaxoSmithKline (GSK)'s Profits As Copy Of Top Asthma Drug Lauches In Germany, Sweden 9/2/2014
BioTie Therapies Corp.: Selincro Enters The Market In Germany 8/29/2014
Fresenius Kabi AG Introduces Acetylcysteine Solution 10% In 4 Ml, 10 Ml And 30 Ml Vials 8/18/2014
Sanofi (France) (SAN.PA), PATH Roll Out First Large-Scale Batches Of Antimalarial Drug 8/12/2014
Another Controversial High Price Med: National Institute for Clinical Excellence (NICE) Rejects Roche (RHHBY)'s New $152,850 Breast Cancer Drug 8/11/2014
Fresenius Kabi AG Release: Diprivan® (Propofol) Injectable Emulsion, USP Now Available In 10 Ml Vials 8/11/2014
Alexza Pharmaceuticals, Inc. (ALXA) Announces The Launch Of ADASUVE® (Inhalation Powder, loxapine) In Guatemala 8/8/2014
bioCSL Inc. Launches AFLURIA® Shipping Campaign For 2014-2015 Seasonal Influenza 8/5/2014
Troubled GlaxoSmithKline (GSK) Gets A Lift As Express Scripts Inc. Reinstates Lung Drug Advair 8/5/2014
Certara Corporation Launches D360 In Japan To Improve Drug Discovery And Development Productivity 8/4/2014
INNOPHARMA Announces Launch Of Olanzapine For Injection, 10mg/Vial In Canada 7/30/2014
AstraZeneca PLC (AZN) Fights With Pediatrician Group Over Preemie Drug Guidelines 7/29/2014
Perrigo Company (PRGO) Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% 7/28/2014
FDA Approves Flonase® Allergy Relief For Sale Over-The-Counter In The United States 7/24/2014
Iroko Pharmaceuticals Continues To Expand Commercialization Of ZORVOLEX Ex-US 7/22/2014
BioTie Therapies Corp.: Selincro Enters The Market In Spain 7/22/2014
Shire Release: Firazyr®: First Subcutaneous Treatment For Acute Attacks Of Rare And Serious Swelling Disorder Now Available In Canada 7/21/2014
BioAlliance Pharma Announces The Launch Of Sitavig® In The United States By Its Partner Innocutis 7/21/2014
Basilea Pharmaceutica (BSLN.SW) To Launch Zevtera®/Mabelio®) (ceftobiprole medocaril) In Europe Through A Commercial Services Provider 7/21/2014
Bial And moksha8 Announce Exclusive License For The Commercialization Of Eslicarbazepine Acetate (Zebinix® / Exalief®) In Brazil And Mexico 7/15/2014
EU Nations Join Forces Against Gilead Sciences, Inc. (GILD)'s "Exorbitant" Hepatitis C Drug 7/14/2014
NicOx SA (COX.PA) Focuses U S. Operations On National Launches Of Sjo™ And Retnagene™ And Restructures RPS® Licensing Agreement 7/10/2014
The International Myeloma Foundation Says IMNOVID® (Pomalidomide), The Newest Medication For Advanced Cases Of Multiple Myeloma, Is Approved For Reimbursement In Sweden, Spain, And Switzerland 7/10/2014
Tianyin Pharmaceutical Co, Inc. Receives GMP For Tablets Formulation In Early July 7/7/2014
Novartis AG (NVS) Unveils Stronger Drug In Bid To Boost Malaria Treatment 7/7/2014
Novartis AG (NVS) Begins Shipment Of Seasonal Influenza Vaccines To US Market For The 2014-2015 Season 7/3/2014
Biogen Idec Canada Release: British Columbia To Reimburse TECFIDERA™, A First-Line Oral Treatment For Multiple Sclerosis 6/25/2014
Dr. Reddy's Laboratories Ltd. (RDY) Announces The Launch Of Paricalcitol Capsules 6/25/2014
Sucampo Pharmaceuticals, Inc. (SCMP) Release: AMITIZA® (Lubiprostone) Receives National Institute for Clinical Excellence (NICE) Recommendation 6/18/2014
UK's Cost Agency Not Ready To Back Gilead Sciences, Inc. (GILD)'s Controversial Hepatitis C Drug 6/17/2014
Cepheid (CPHD) Announces European Release Of Xpert Carba-R, A Molecular Test For Rapid And Accurate Detection Of Carbapenemase-Producing Gram-Negative Bacteria 6/16/2014
Takeda Pharmaceutical Co. Ltd. (TKPYY) Release: ENTYVIO™ (vedolizumab) Now Available In The United States For The Treatment Of Adults With Moderately To Severely Active Ulcerative Colitis And Crohn's Disease 6/16/2014
Italy To Fund Unapproved Use Of Roche (RHHBY) Drug To Cut Costs; Move Startles The Industry 6/13/2014
Medivir AB (MVRBF) Release: OLYSIO™ Available Soon In All Nordic Countries For The Treatment Of Adults With Hepatitis C Genotype 1 And 4 Infection 6/10/2014
Both Are Roche (RHHBY)'s Drugs, But Which One Could Save The U.S. $3 Billion? 6/5/2014
Genzyme Corporation (GENZ)'s Lemtrada Recommended For Reimbursement On NHS By The National Institute for Clinical Excellence (NICE) 5/28/2014
Polyplus Transfection Launches A New Transfection Reagent For Bioproduction 5/28/2014
ULURU Inc. Announces Shipments Of Altrazeal® To Italy, Spain And Portugal 5/27/2014
TOLMAR Pharmaceuticals Established To Market ELIGARD For Advanced Prostate Cancer In The U.S. And Puerto Rico 5/16/2014
Actavis (ACT) Launches Generic Version Of Catapres-TTS® 5/8/2014
Otsuka Pharmaceutical Co., Ltd. Release: New Once-Monthly Treatment For Schizophrenia, ABILIFY MAINTENA™ (Aripiprazole For Prolonged Release Injectable Suspension), Now Available In Canada 5/5/2014
Medivir AB (MVRBF) Release: Adasuve Will Now Be Launched In Sweden, Norway, Finland, And Denmark 4/30/2014
Heat On Roche (RHHBY) To Cut Kadcyla Price After National Institute for Clinical Excellence (NICE) Says "No" 4/23/2014
Stolen Roche (RHHBY) Cancer Drug Found On Market 4/18/2014
Ferring Pharmaceuticals Release: UK National Institute for Clinical Excellence (NICE) Guidance Recommends FIRMAGON® (Degarelix) For The Treatment Of Advanced Hormone-Dependent Prostate Cancer Only In People With Spinal Metastases Who Present With Signs Or Symptoms Of Impending Spinal Cord Compression (ISCC) 4/15/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of Generic Lunesta® Tablets In The United States 4/15/2014
Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS) Plans To Gradually Phase-Out Of Ranbaxy Laboratories (RANBAXY.BO)-Branded Drugs In U.S. 4/9/2014
Swedish Orphan Biovitrum Becomes Market Authorisation Holder For Xiapex In Europe 4/7/2014
Aerocrine Release: National Institute for Clinical Excellence (NICE) Recommends The Use Of Exhaled Nitric Oxide (Feno) Testing To Help Diagnose And Manage Asthma 4/2/2014
Swedish Orphan Biovitrum Assumes Direct Responsibility For Orfadin® (Nitisinone) In U.S. And Canada And Introduces Orfadin4U™ 4/1/2014
Sanofi (France) (SAN.PA) Release: National Institute for Clinical Excellence (NICE) Rejects Life-Extending Bowel Cancer Drug Two Weeks After Scottish Approval 3/25/2014
UK Cancer Drugs Fund Adds Roche (RHHBY), Celgene Corporation (CELG) And Exelixis, Inc. (EXEL) Drugs 3/24/2014
UK Cost Agency Says "No" To Bayer AG (BAYN.DE) Prostate Cancer Drug Xofigo 3/24/2014
H. Lundbeck A/S (LUN.CO) And Otsuka Pharmaceutical Co., Ltd. Initiate European Launch Of Abilify Maintena® (Aripiprazole), A Once-Monthly Formulation For The Treatment Of Schizophrenia 3/17/2014
NicOx SA (COX.PA) Launches Adenoplus® And Xailin™ Dry Eye Product Range In Europe 3/17/2014
Alexza Pharmaceuticals, Inc. (ALXA) And Ferrer Internacional Announce The Launch Of ADASUVE® (Inhalation Powder, Loxapine) In Romania 3/14/2014
Sucampo Pharmaceuticals, Inc. (SCMP) Receives Notice That Second Indication For AMITIZA For Opioid-Induced Constipation Is Not Approved By Medicines And Healthcare Products Regulatory Agency In U.K. 3/13/2014
Roche (RHHBY) And Jiangsu Province Bring Down High Cost Of Breast Cancer Drug 3/13/2014
French Competition Regulator Probes Roche (RHHBY), Novartis AG (NVS) 3/12/2014
Novartis AG (NVS) Muscle Drug Sales May Reach $4 Billion, According To MorphoSys AG 3/7/2014
British Watchdog Wants U.S. Biotech Alexion Pharmaceuticals Inc. (ALXN) To Justify Cost Of Drug 3/5/2014
Teva Pharmaceutical Industries Limited (TEVA) Launches ADASUVE® In U.S. 3/3/2014
Bayer AG (BAYN.DE) Eyes At Least 7.5 Billion Euros In Sales From Five Key Drugs 2/28/2014
Essex Medipharma To Distribute Pfizer Inc. (PFE) Glaucoma Eye Drops In China 2/25/2014
Double-Crane Pharmaceutical Co., Ltd. To Distribute Sagent Pharmaceuticals, Inc. Pediatric Drug In China 2/14/2014
Jazz Pharmaceuticals plc (JAZZ) Announces U.S. Commercial Availability Of Versacloz™ (clozapine, USP) Oral Suspension 2/12/2014
Mylan Inc. (MYL) Launches First Trastuzumab Biosimilar, Hertraz™, In India 2/3/2014
Alexza Pharmaceuticals, Inc. (ALXA) Announces Grupo Ferrer Internacional S.A.'s Launch Of ADASUVE® (Staccato® Loxapine) In Spain Triggering A $1 Million Milestone Payment 1/23/2014
Eisai Company, Ltd. (ESALY.PK) Announces Launch Of New "Crystal Veil Mask Bokin 24 Mint" Face Mask Spray Containing Long-Acting Antimicrobial Agent Etak 1/22/2014
H. Lundbeck A/S (LUN.CO)'s Brintellix® (Vortioxetine) For The Treatment Of Major Depressive Disorder In Adults Is Now Available In U.S. Pharmacies 1/21/2014
BioCon Limited (BIOCON.NS) Hits Roche (RHHBY) First, Set To Launch Biosimilar Of Breast Cancer Drug Herceptin 1/21/2014
Vectura Group plc (VEC.L)'s AirFluSal® Forspiro® Launched In Denmark 1/20/2014
Roche (RHHBY) Resolves U.S. Shortage Of Tamiflu For Children 1/17/2014
Seattle Genetics, Inc. (SGEN) Announces ADCETRIS® (Brentuximab Vedotin) Approval In Japan For The Treatment Of Relapsed Or Refractory Hodgkin Lymphoma And Anaplastic Large Cell Lymphoma 1/17/2014
Biogen Idec, Inc. (Massachusetts) (BIIB) Announces Availability Of FAMPYRA® In Ireland To Treat Walking Impairment In Adults With Multiple Sclerosis 1/15/2014
pSivida Corp (PSDV) Reports First Orders For ILUVIEN® Shipped For U.K. National Health Service Hospitals Less Than Seven Weeks After Final National Institute for Clinical Excellence (NICE) Guidance 1/13/2014
UK Lawmakers Criticizes The Government For Spending $702 Million On Roche (RHHBY)'s Tamiflu When Some Researchers Doubt The Medicine's True Efficacy 1/6/2014
Eisai Company, Ltd. (ESALY.PK) Announces Launch of Antiepileptic Drug Fycompa In U.S. 1/6/2014
China Halts Imports Of Pfizer Inc. (PFE)'s Diflucan On Paperwork Glitch 12/31/2013
PhotoCure Release: Regulatory Update On Cevira 12/27/2013
Ipsen (IPN.PA) Prepares For The Resupply Of Increlex® In Europe 12/18/2013
MediGene AG (MDGEF.PK)'s Drug Veregen® Launched In Norway And Sweden 12/18/2013
Health Canada Issues Notice Of Compliance For Gilead Sciences, Inc. (GILD)'s Sovaldi™ (Sofosbuvir) For The Treatment Of Chronic Hepatitis C 12/16/2013
AstraZeneca PLC (AZN) And Bristol-Myers Squibb Company (BMY) Pull Diabetes Drug From Germany 12/16/2013
Notices Sent To Ranbaxy Laboratories (RANBAXY.BO), Cipla Ltd. For Overcharging 12/10/2013
Medivir AB (MVRBF)'s Simeprevir Is Now Available For Hepatitis C Patients In Japan, USA And Canada 12/10/2013
EU Agency Starts In-Depth Review Of Ariad Pharmaceuticals, Inc. (ARIA) Leukemia Drug 12/6/2013
Pfizer Inc. (PFE), Hanmi Pharmaceutical, Co., Ltd Brawl Over Design Of Viagra Pill 12/5/2013
Teva Pharmaceutical Industries Limited (TEVA) Announces Additional Regulatory Exclusivity For TREANDA® (Bendamustine HCI) For Injection 11/27/2013
FDA Lifts Constraints On GlaxoSmithKline (GSK) Diabetes Drug Avandia 11/26/2013
Sosei Group Corporation: Once-Daily Ultibro® Inhalation Capsules (QVA149) For COPD Launched In Japan 11/20/2013
Skyepharma PLC (SKYEF)'s Partner Kyorin Launches Flutiform® In Japan 11/19/2013
WuXi PharmaTech Co., Ltd. To Produce New Cancer Drug For Pharmacyclics, Inc. (PCYC) 11/15/2013
NicOx SA (COX.PA) Launches Sjö™ In The U.S. And Partners With The Sjogren's Syndrome Foundation 11/12/2013
Allied Healthcare Group (AHZ:AU) Makes First Sale of Cardiocel ® Into Europe 11/8/2013
National Institute for Clinical Excellence (NICE): Final Draft OK for Lucentis in Rare Eye Condition 10/25/2013
ADImmune Corporation of Taiwan Readies Flu Vaccine for China 10/25/2013
National Institute for Clinical Excellence (NICE) Draft "Yes" for Astellas Pharma Inc. (ALPMY)' Prostate Cancer Drug 10/18/2013
China National Biotech Group's Japanese Encephalitis Vaccine Prequalified by World Health Organization 10/9/2013
Teva Pharmaceutical Industries Limited (TEVA) Sees Obstacles to Copying GlaxoSmithKline (GSK)'s Best-Selling Drug Advair Before 2018 10/9/2013
National Institute for Clinical Excellence (NICE) Backs Roche (RHHBY)'s MabThera in Rare Autoimmune Disease 10/3/2013
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch of Generic Zemplar® in the United States 10/1/2013
Lundbeck Inc. (LUN.CO) Launches Selincro® in Denmark 9/30/2013
BioTie Therapies Corp.: Selincro Enters the Market in Italy 9/26/2013
Sun Pharmaceutical Industries Ltd May Get Windfall Gains on Cancer Drug Doxil 9/26/2013
Teva Pharmaceutical Industries Limited (TEVA) Copy to Boost Billionaire-Backed Drugmaker 9/18/2013
National Institute for Clinical Excellence (NICE) Demands More Data for Sanofi (France) (SAN.PA)'s Oral MS Drug 9/18/2013
Eisai Company, Ltd. (ESALY.PK)'s EMEA Ops to Supply Fycompa in U.S. 9/12/2013
GlaxoSmithKline (GSK) Declines as FDA Clears Path for Advair Rivals, $8 Billion in Revenue Threatened 9/10/2013
Orexo AB Provides Update on Reimbursement and Launch Preparations for Zubsolv® 9/5/2013
Government Seeks Evidence on PBS-Listed Cancer Drug Yervoy 8/26/2013
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces the Launch of Divalproex Sodium Extended - Release Tablets, USP 8/22/2013
Pfizer Inc. (PFE) Lung Cancer Drug Xalkori Faces UK Rejection as Too Costly 8/19/2013
Moberg Pharma AB (Formerly known as Moberg Derma) Launches Kerasal® NeuroCream at Walmart and Major U.S. Drugstores 8/12/2013
Teva Pharmaceutical Industries Limited (TEVA) and Perrigo Company (PRGO) Announce the U.S. Launch of Generic Temozolomide 8/12/2013
Moberg Pharma AB (Formerly known as Moberg Derma) Launches Kerasal® NeuroCream at Walmart and Major U.S. Drugstores 8/12/2013
XstalBio Launches CentuRecon™ to Accelerate the Delivery of Biologic Drugs at High Concentration 8/12/2013
UK Cost Agency Turns Down New Roche (RHHBY) Breast Cancer Drug 8/6/2013
Roche (RHHBY) Cuts Cost of Drug to Prevent Blindness in HIV Patients 8/6/2013
Zealand Pharma Informs That Sanofi (France) (SAN.PA) has Provided an Update on the Commercial Roll-Out of Lyxumia® 8/1/2013
Teva Pharmaceutical Industries Limited (TEVA)'s Morning-After Pill Now Available on Store Shelves 8/1/2013
BTG plc (BTG.L) Release: TheraSphere® Recommended by the National Institutes of Health (NIH) for the Treatment of Primary and Secondary Liver Cancer 7/30/2013
Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Launch of Donepezil Hydrochloride Tablets, 23 mg 7/29/2013
Teva Pharmaceutical Industries Limited (TEVA) Gets Exclusivity on Plan B Contraceptive 7/24/2013
Errors, Misconduct, and an Alleged Cover-Up Attempt Delayed Pfizer Inc. (PFE), Bristol-Myers Squibb Company (BMY) Medicine 7/15/2013
Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Launch of Decitabine for Injection 7/12/2013
A Bayer AG (BAY.F) Drug, the European Medicines Agency and Transparency... or the Lack Thereof 7/11/2013
UK Health Watchdog Doesn't Recommend Novartis AG (NVS)'s Afinitor 7/8/2013
Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Launch of Lamotrigine Extended-Release Tablets 6/26/2013
Eisai Inc. (ESALF.PK) to Pull Epilepsy Drug From Germany 6/26/2013
Actavis (ACT) Launches Generic Viagra® in Europe as Patents Expire 6/24/2013
UK's National Institute for Clinical Excellence (NICE) Rejects Sanofi (France) (SAN.PA) Bowel Cancer Drug 6/21/2013
SkyePharma Inc. (SKYE) Release: flutiform® Launch in Italy Triggers €2 Million Milestone From Marketing Partner Mundipharma AG 6/20/2013
Novo Nordisk A/S (NVO) Drops as New Eli Lilly and Company (LLY) Drug Threatens Victoza 6/18/2013
Takeda Pharmaceutical Co. Ltd. (TKPYY) Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 6/17/2013
Obama Administration Reverses Course on Teva Pharmaceutical Industries Limited (TEVA)'s Plan B Pill 6/11/2013
TiGenix Provides ChondroCelect Update 6/10/2013
FDA Weighs Lifting Safety Restrictions on GlaxoSmithKline (GSK)'s Avandia 6/6/2013
Sacre Bleu! European Agency Rebuffs French Regulator Over Bayer AG (BAY.F) Acne Pill 5/30/2013
Eisai Company, Ltd. (ESALY.PK) Announces Launch of Antiepileptic Agent Inovelon® Tablets 100 mg, 200 mg in Japan 5/28/2013
MEDA: Dymista Reimbursed in Sweden 5/23/2013
Immune Response BioPharma Sets Pricing of REMUNE Vaccine in Thailand Between $75 -100 Per Dose 5/20/2013
EMD Millipore Launches OsteoMAX-XF™, a Fully-Defined, Xeno-Free Mesenchymal Stem Cell Osteogenic Differentiation Medium 5/9/2013
Merck & Co., Inc. (MRK), GlaxoSmithKline (GSK) Reduce HPV Vaccine Prices by 95 Pct. in Poorest Regions 5/9/2013
Non Profit to Bayer AG (BAY.F): Withdraw False Vitamin Claims or Else! 5/9/2013
BioTie Therapies Corp.: Selincro Launched in the United Kingdom 5/6/2013
BioTie Therapies Corp.: Selincro Launched in the United Kingdom 5/6/2013
Retractions?! Conflicts?! Novartis AG (NVS) Probes Diovan Research 5/3/2013
Martindale Pharma® Launches Tapclob®, the First Licensed Oral Liquid Suspension of Clobazam 5/1/2013
EMD Millipore Launches OsteoMAX-XF™, a Fully Defined, Xeno-free Mesenchymal Stem Cell Osteogenic Differentiation Medium 4/30/2013
BioTie Therapies Corp.: Selincro Launched in First European Markets 4/22/2013
Cipla Ltd. Launches Shanghai CP Guojian's Biosimilar in India 4/19/2013
GlaxoSmithKline (GSK)'s Contract Manufacturing Delays Cause Shortage of Restless Leg Treatment 4/18/2013
European Medicines Agency Staff Push to Restrict Servier Osteoporosis Drug 4/15/2013
Dr. Reddy's Laboratories Ltd. (RDY)'s Withdraws Muscle Relaxant From the U.S. 4/11/2013
GW Pharmaceuticals' Cannabinoid-Medicine Sativex® Moved to Schedule 4 of UK Drugs Act 4/10/2013
Novartis AG (NVS) Blockbuster Linked to Retracted Papers 4/2/2013
Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Launch of Zenatane™ (Isotretinoin Capsules USP) 3/29/2013
Pharming Group (PHGUF.PK) Announces European Medicines Agency Approval of New Manufacturing Site for Ruconest® 3/28/2013
National Institute for Clinical Excellence (NICE) Issues Draft "No" for Pfizer Inc. (PFE)'s Xalkori, but Opens Consultation 3/28/2013
FDA Perspective Published in The New England Journal of Medicine Reinforces Safety of Boehringer Ingelheim Corporation's Pradaxa® (dabigatran etexilate) 3/26/2013
BASF Increases Prices for N,N-Dimethylformamide 3/25/2013
FDA Denies Approval for GlaxoSmithKline (GSK) Bird Flu Vaccine 3/25/2013
GW Pharmaceuticals, Almirall May Pull Cannabis Drug in German Price Row 3/20/2013
Sanofi (France) (SAN.PA): U.S. Probes Disclosures to FDA About Patient Response to Plavix 3/11/2013
Novartis AG (NVS), Roche (RHHBY) Accused by Italy of Eye Drug "Cartel" 2/22/2013
R-Tech Ueno: Announcement of Commercial Availability of RESCULA® Eye Drops in the U.S. Market 2/21/2013
Novartis AG (NVS)'s Jakavi Turned Down by National Institute for Clinical Excellence (NICE) for Blood Cancer 2/13/2013
Ipsen (IPN.PA) Release: Eziclen® / Izinova® a New Product for Bowel Cleansing Successfully Completed European Decentralised Registration Procedure 2/7/2013
Luqa Pharmaceuticals Launches Strataderm® in China 2/1/2013
UK's National Institute for Clinical Excellence (NICE) Rejects Genentech (RHHBY)'s Avastin for Ovarian Cancer 2/1/2013
European Commission (EC) Charges Johnson & Johnson (JNJ) and Novartis AG (NVS) With Pay-to-Delay 1/31/2013
GlaxoSmithKline (GSK) Vaccine Linked to 800 Children Narcolepsy Cases in EU 1/28/2013
AGNSS Recommends Alexion Pharmaceuticals Inc. (ALXN)'s Soliris® (eculizumab) for aHUS and Concludes "Eculizumab Would Help Save Lives and Improve the Quality of Life for Children and Adults With Atypical Haemolytic Uraemic Syndrome" 1/24/2013
Bristol-Myers Squibb Company (BMY), Pfizer Inc. (PFE) Drug Wins National Institute for Clinical Excellence (NICE) Nod for Irregular Heartbeats 1/23/2013
Teijin Pharma to Launch Ipsen (IPN.PA)'s Somatuline® Subcutaneous Injection in the Treatment of Acromegaly and Pituitary Gigantism in Japan 1/17/2013
India Takes Another Swipe at Big Pharmas Such as Bristol-Myers Squibb Company (BMY), Roche (RHHBY); Govt. to Make 3 Key CA Drugs Cheaper 1/14/2013
Journal Refuses to Retract GlaxoSmithKline (GSK)'s Controversial Paxil Study 1/10/2013
Forest Laboratories, Inc. (FRX) and Almirall Announce Commercial Availability of Tudorza™ Pressair™ in U.S. Pharmacies 12/11/2012
National Institute for Clinical Excellence (NICE) Says "No" on Pfizer Inc. (PFE) Kidney Cancer Drug 12/7/2012
Tanzania Expands Immunization Program to Include Pfizer Inc. (PFE)'s Prevenar 13 for Prevention of Pneumococcal Disease 12/5/2012
curasan AG (DX:CUR) Now Sells Bone Regeneration Material in Injectable Form 12/5/2012
Sucampo Pharmaceuticals, Inc. and Abbott Laboratories (ABT) Announce Launch of AMITIZA in Japan 11/26/2012
Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Launch of SILDENAFIL TABLETS 11/19/2012
Bayer AG (BAY.F) Bets $4 Billion on R8D and Sales From 5 Blockbuster Drugs 11/14/2012
Roche (RHHBY) Fails to Address Question of Missing Tamiflu Data 11/14/2012
Sanofi (France) (SAN.PA) Halves Price of Cancer Drug After Rejection From Cancer Center 11/9/2012
National Institute for Clinical Excellence (NICE) Rejects Novartis AG (NVS) Asthma Drug in Change of Tack 11/9/2012
Cipla Ltd. Slashes Cancer Drug Prices by Up to 64 Pct 11/8/2012
AstraZeneca PLC (AZN), PTSD and a Buried Seroquel Study 11/8/2012
British Medical Journal Pushes Roche (RHHBY) for Raw Data on Tamiflu Trials 10/31/2012
Phagenesis Ltd Launches First Treatment for Acute Dysphagia 10/25/2012
NicOx SA (COX.PA) Launches AdenoPlus™ in the United States 10/22/2012